• Accelerator

Admetsys

  • Health
  • Cohort 1 2019
  • Alumni
  • Accelerator

Admetsys

  • Health
  • Cohort 1 2019
  • Alumni

What They Do

For people at diabetic risk, glucose control is at its most crucial while in hospital or surgery. Admetsys has developed a smart device that actively measures patient blood glucose levels in real time and actively corrects abnormal glucose levels in response to fluctuations. This helps speed recovery, prevents infection and reduces complications.

from USA

About the founder

The founding team is led by Jeff Valk, Chief Executive Officer, a seasoned leader of highly technical organizations, and a hardware and software engineer specializing in design of adaptive systems. Research and clinical operations are headed by Dr. Tim Valk, Chief Scientist, a board certified endocrinologist, researcher, and former professor with over 25 years in clinical practice.

Regulatory, supply chain, and internal operations are headed by Glenn Robertelli, Chief Operating Officer, a medical industry veteran and global supply chain expert.

Testimonials from this Member

Glenn Robertelli, Chief Operating Officer

In many countries the meetings are very cold and it takes time for people to get to know each other, however we have noticed that even when we sit down with people we’ve never met before, the conversation is much more comfortable and you tend to open up and talk about everything! You don’t feel like you have to hold back as the people are very supportive. It’s a place where people connect.

In the early stages we were a few people in a garage where no one knows about us, but to shift that into an enterprise, we had to get out there and meet people. So taking the opportunity helped us grow and become more established, and with the MBRIF initially, we started our footsteps into this region. These relationships are unblocking our growth.

Initiative by

Supported by